Morten Ruhwald
Morten Ruhwald
Foundation of Innovative New Diagnostics
Bestätigte E-Mail-Adresse bei - Startseite
Zitiert von
Zitiert von
Towards tuberculosis elimination: an action framework for low-incidence countries
K Lönnroth, GB Migliori, I Abubakar, L D'Ambrosio, G De Vries, R Diel, ...
European Respiratory Journal 45 (4), 928-952, 2015
Interferon-γ release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis
R Diel, D Goletti, G Ferrara, G Bothamley, D Cirillo, B Kampmann, ...
European Respiratory Journal 37 (1), 88-99, 2011
Latent tuberculosis in HIV positive, diagnosed by the M. tuberculosis specific interferon-γ test
I Brock, M Ruhwald, B Lundgren, H Westh, LR Mathiesen, P Ravn
Respiratory research 7 (1), 1-9, 2006
Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis
M Ruhwald, T Bodmer, C Maier, M Jepsen, MB Haaland, J Eugen-Olsen, ...
European respiratory journal 32 (6), 1607-1615, 2008
A novel liposomal adjuvant system, CAF01, promotes long-lived Mycobacterium tuberculosis-specific T-cell responses in human
JT van Dissel, SA Joosten, ST Hoff, D Soonawala, C Prins, DA Hokey, ...
Vaccine 32 (52), 7098-7107, 2014
Point‐of‐care diagnosis of tuberculosis: Past, present and future
K Dheda, M Ruhwald, G Theron, J Peter, WC Yam
Respirology 18 (2), 217-232, 2013
Beyond the IFN-γ horizon: biomarkers for immunodiagnosis of infection with Mycobacterium tuberculosis
NN Chegou, J Heyckendorf, G Walzl, C Lange, M Ruhwald
European Respiratory Journal 43 (5), 1472-1486, 2014
IP-10 release assays in the diagnosis of tuberculosis infection: current status and future directions
M Ruhwald, MG Aabye, P Ravn
Expert review of molecular diagnostics 12 (2), 175-187, 2012
CXCL10/IP-10 release is induced by incubation of whole blood from tuberculosis patients with ESAT-6, CFP10 and TB7. 7
M Ruhwald, M Bjerregaard-Andersen, P Rabna, K Kofoed, J Eugen-Olsen, ...
Microbes and infection 9 (7), 806-812, 2007
Prednisolone treatment affects the performance of the QuantiFERON gold in-tube test and the tuberculin skin test in patients with autoimmune disorders screened for latent …
E Bélard, S Semb, M Ruhwald, AM Werlinrud, B Soborg, FK Jensen, ...
Inflammatory bowel diseases 17 (11), 2340-2349, 2011
IP-10, MCP-1, MCP-2, MCP-3, and IL-1RA hold promise as biomarkers for infection with M. tuberculosis in a whole blood based T-cell assay
M Ruhwald, M Bjerregaard-Andersen, P Rabna, J Eugen-Olsen, P Ravn
BMC research notes 2 (1), 1-6, 2009
Improving T-cell assays for the diagnosis of latent TB infection: potential of a diagnostic test based on IP-10
M Ruhwald, J Petersen, K Kofoed, H Nakaoka, LE Cuevas, L Lawson, ...
PloS one 3 (8), e2858, 2008
Antigen availability shapes T cell differentiation and function during tuberculosis
AO Moguche, M Musvosvi, A Penn-Nicholson, CR Plumlee, H Mearns, ...
Cell host & microbe 21 (6), 695-706. e5, 2017
A multicentre evaluation of the accuracy and performance of IP-10 for the diagnosis of infection with M. tuberculosis
M Ruhwald, J Dominguez, I Latorre, M Losi, L Richeldi, MB Pasticci, ...
Tuberculosis 91 (3), 260-267, 2011
Optimization and Interpretation of Serial QuantiFERON Testing to Measure Acquisition of Mycobacterium tuberculosis Infection
E Nemes, V Rozot, H Geldenhuys, N Bilek, S Mabwe, D Abrahams, ...
American journal of respiratory and critical care medicine 196 (5), 638-648, 2017
Correlates for disease progression and prognosis during concurrent HIV/TB infection
JFD Siawaya, M Ruhwald, J Eugen-Olsen, G Walzl
International journal of infectious diseases 11 (4), 289-299, 2007
Safety and immunogenicity of the chlamydia vaccine candidate CTH522 adjuvanted with CAF01 liposomes or aluminium hydroxide: a first-in-human, randomised, double-blind, placebo …
S Abraham, HB Juel, P Bang, HM Cheeseman, RB Dohn, T Cole, ...
The Lancet infectious diseases 19 (10), 1091-1100, 2019
Safety and efficacy of the C-Tb skin test to diagnose Mycobacterium tuberculosis infection, compared with an interferon γ release assay and the tuberculin skin test: a phase 3 …
M Ruhwald, H Aggerbeck, RV Gallardo, ST Hoff, JI Villate, B Borregaard, ...
The Lancet Respiratory Medicine 5 (4), 259-268, 2017
Potential of interferon-γ-inducible protein 10 in improving tuberculosis diagnosis in HIV-infected patients
MG Aabye, M Ruhwald, G Praygod, K Jeremiah, M Faurholt-Jepsen, ...
European Respiratory Journal 36 (6), 1488-1490, 2010
Sensitivity of C-Tb: a novel RD-1-specific skin test for the diagnosis of tuberculosis infection
ST Hoff, JG Peter, G Theron, M Pascoe, PN Tingskov, H Aggerbeck, ...
European Respiratory Journal 47 (3), 919-928, 2016
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20